Human Microbiome Sequencing Market: By Microbes; Anatomy; Technology; Disorder; Diagnosis; Application; & Geography - Forecast 2018 to 2023

Human microbiome is a collective genome of microorganisms that reside inside and outside of the body ranging from pathogenic to beneficial. Microbiota hosts on a biotic as well as an abiotic body.

The Human Microbiome Sequencing market is broadly classified on the basis of various parameters. The market has been divided based on types of microbes- Bacteria, Archae, Fungi and Virus. On the basis of human anatomy- Skin, Conjunctiva, Gut, Other body parts. The segmentation is also by the sequencing technology- Traditional and Next Generation. On the basis of Disorders, the market has been segmented as Gastrointestinal, Metabolic, Oncology and other serious disorders and on the basis of diagnosis- analyzers, reagents and other solutions. The market has been split by the application areas such as Healthcare & Pharmaceuticals, Food & Beverage and others also by End-Users in Testing Centres, Research Labs and other areas, as well as based on geographical analysis.

The market is led by U.S. region as the the growing number of startups and huge investments by ventures in pharmaceutical and medical fields, as well as food & beverage industry drive the growth. The growing healthcare tourism in Middle East and APAC regions will significantly drive the market for Human Microbiome Sequencing in these markets. APAC region will have the fastest growing market during the forecast period as improving medical infrastructure and growing programs driving medical procedures in this region drive the market.
Key market players- uBiome, Evolve BioSystems, Epibiome and many others. The advancement in medical and food technologies and continuous investments by big industry tycoons and government, and penetration of start-ups in this market, indicates better prospective in Microbiome Sequencing Market.